You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bromodomain and extra terminal domain (BET) proteins

Showing 1 - 25 of 5,823
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Childhood, Lymphoma, Brain Tumor, Pediatric Trial in Canada, United States (BMS-986158, BMS-986378)

Recruiting
  • Solid Tumor, Childhood
  • +2 more
  • Boston, Massachusetts
  • +5 more
Dec 27, 2022

AML Including AML de Novo and AML Secondary to MDS, DLBCL Trial (Birabresib Dose 20 mg)

Terminated
Has Results
  • AML Including AML de Novo and AML Secondary to MDS
  • DLBCL
  • Birabresib Dose 20 mg
  • (no location specified)
Aug 23, 2022

NUT Midline Carcinoma, Triple Negative Breast Cancer, NSCLC With Rearranged ALK Gene/Fusion Protein or KRAS Mutation Trial

Completed
Has Results
  • NUT Midline Carcinoma
  • +5 more
  • (no location specified)
Jan 7, 2021

Glioblastoma Multiforme Trial (Birabresib)

Terminated
Has Results
  • Glioblastoma Multiforme
  • (no location specified)
Jan 7, 2021

NUT Midline Carcinoma (NMC), Triple Negative Breast Cancer (TNBC), NSCLC (NSCLC) Trial (Birabresib)

Terminated
Has Results
  • NUT Midline Carcinoma (NMC)
  • +3 more
  • (no location specified)
Jan 7, 2021

Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +148 more
Oct 10, 2022

Squamous Cell Lung Cancer Trial in United States (ZEN003694)

Recruiting
  • Squamous Cell Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
Nov 1, 2022

Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET

Suspended
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • Boston, Massachusetts
    Dana-Farber - Harvard Cancer Center LAO
Sep 17, 2022

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Pittsburgh (ZEN003694, Talazoparib)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Apr 27, 2022

Diabetes, Type 2, Coronary Artery Disease Trial in Worldwide (Apabetalone, Placebo, Atorvastatin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Coronary Artery Disease
  • Bahía Blanca, Argentina
  • +213 more
Jul 23, 2021

Advanced Malignant Tumors Trial in Guangzhou, Hangzhou (TQB3617)

Recruiting
  • Advanced Malignant Tumors
  • Guangzhou, Guangdong, China
  • +1 more
Feb 11, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Boston, Galveston,

Suspended
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Boston, Massachusetts
  • +2 more
Oct 5, 2022

Multiple Myeloma Trial in Australia, United Kingdom, United States (RO6870810, daratumumab)

Completed
  • Multiple Myeloma
  • Duarte, California
  • +11 more
Feb 6, 2020

Metastatic Colorectal Adenocarcinoma, Refractory Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial (drug,

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +2 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +6 more
  • (no location specified)
Oct 25, 2023

Pulmonary Arterial Hypertension Trial in Calgary, Quebec City (Apabetalone)

Completed
  • Pulmonary Arterial Hypertension
  • Calgary, Alberta, Canada
  • +1 more
Apr 22, 2022

Acute Myeloid Leukemia Trial (ABBV-787)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 29, 2023

Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +7 more
  • Atlanta, Georgia
  • +2 more
Nov 3, 2022

Hematopoietic and Lymphoid System Tumor, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial (BET

Not yet recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +5 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +6 more
  • (no location specified)
Apr 6, 2023

Duchenne Muscular Dystrophy Trial in Little Rock (RGX-202)

Recruiting
  • Duchenne Muscular Dystrophy
  • RGX-202
  • Little Rock, Arkansas
    Arkansas Children's Hospital
Jan 12, 2023

Solid Tumors, Advanced Malignancies, Metastatic Cancer Trial in Spain, United Kingdom, United States (Azacitidine,

Terminated
Has Results
  • Solid Tumors
  • +2 more
  • Duarte, California
  • +11 more
Apr 13, 2021

Smoking Cessation Trial in Wilmington (contingency management (deposit contract), leaderboard and social feed, smoking cessation

Recruiting
  • Smoking Cessation
  • contingency management (deposit contract)
  • +2 more
  • Wilmington, Delaware
    WayBetter
Nov 22, 2022

Eustachian Tube Dysfunction Trial (Balloon Eustachian Tuboplasty (BET) under general anesthesia., Insertion of catheter for

Not yet recruiting
  • Eustachian Tube Dysfunction
  • Balloon Eustachian Tuboplasty (BET) under general anesthesia.
  • Insertion of catheter for probing and flushing the Eustachian tube under general anesthesia
  • (no location specified)
Aug 9, 2023

Nasopharyngeal Carcinoma by AJCC V8 Stage Trial in China (Nimotuzumab, Gemcitabine, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma by AJCC V8 Stage
  • Baise, Guangxi, China
  • +8 more
Jan 29, 2023

Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)

Not yet recruiting
  • Myelofibrosis
  • TQ05105 Tablets
  • TQB3617 Capsules
  • Guangzhou, Guangdong, China
  • +19 more
Nov 7, 2023